Scientific Advisory Board Member Resigns Due to Conflict with Responsibilities with Important Public Sector Entity
October 15, 2021 18:00 ET
|
Enochian BioSciences, Inc.
LOS ANGELES, Oct. 15, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, a company focused on gene modified cellular and immune therapies for infectious diseases and cancer, announced...
XORTX Therapeutics Announces Closing of US$12 Million Public Offering
October 15, 2021 17:38 ET
|
XORTX Therapeutics Inc.
CALGARY, Alberta, Oct. 15, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX | NASDAQ: XRTX), a pharmaceutical therapeutics company focused on developing...
Lakeland Bancorp Announces Date for Third Quarter Earnings and Conference Call
October 15, 2021 17:14 ET
|
Lakeland Bancorp, Inc.
OAK RIDGE, N.J., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Lakeland Bancorp, Inc. (NASDAQ: LBAI) (the “Company”) announced that it expects to report earnings for the third quarter ended September 30, 2021,...
Avadel Pharmaceuticals Announces Ongoing FDA Review of NDA for FT218 for Patients with Narcolepsy
October 15, 2021 17:00 ET
|
Avadel Pharmaceuticals plc
DUBLIN, Ireland, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, announced today that the U.S. Food and...
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results
October 15, 2021 16:36 ET
|
Cryo-Cell International, Inc.
OLDSMAR, Fla., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store...
Kaiser Aluminum Corporation Announces Quarterly Dividend Payment
October 15, 2021 16:30 ET
|
Kaiser Aluminum Corporation
FOOTHILL RANCH, Calif., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Kaiser Aluminum Corporation (NASDAQ:KALU) today announced that its Board of Directors has declared a quarterly cash dividend of $0.72 per...
Cabaletta Bio Announces Presentation of Preclinical Data Supporting PLA2R-CAART as a Potential Precision Therapy for Antigen-Specific B Cell Depletion in PLA2R Membranous Nephropathy at ASN Kidney Week 2021
October 15, 2021 16:30 ET
|
Cabaletta Bio
– Chimeric AutoAntibody Receptor (CAAR) T cells specifically recognized and eliminated anti-PLA2R antibody-expressing B cells in vitro – – Membrane proteome arrays screened with PLA2R CAAR candidates...
Monolithic Power Systems to Report Third Quarter Results on October 28, 2021
October 15, 2021 16:18 ET
|
Monolithic Power Systems, Inc.
KIRKLAND, Wash., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Monolithic Power Systems, Inc. (MPS) (Nasdaq: MPWR), a global company that provides high-performance, semiconductor-based power electronics...
Rhythm Pharmaceuticals complète la demande de variation de type II à l'Agence européenne des médicaments pour l'IMCIVREE® (setmelanotide) pour les syndromes de Bardet-Biedl et Alström
October 15, 2021 16:11 ET
|
Rhythm Pharmaceuticals, Inc.
BOSTON, 15 oct. 2021 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq : RYTM), une société biopharmaceutique au stade commercial engagée à transformer les soins des personnes atteintes de...
Rhythm Pharmaceuticals schließt die Einreichung des Antrags für die Typ-II-Variation für IMCIVREE ® (Setmelanotid) für Bardet-Biedl- und Alström-Syndrome bei der Europäischen Arzneimittelagentur ab
October 15, 2021 16:11 ET
|
Rhythm Pharmaceuticals, Inc.
BOSTON, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), ein biopharmazeutisches Unternehmen im kommerziellen Stadium, das sich der Umgestaltung der Versorgung von...